Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells

Journal of Cellular Biochemistry

Volumn 75, Issue 4, 1999, Pages 652-664

  Perks, Claire M ^a   Bowen, Samantha ^a   Gill, Zahidah P ^a   Newcomb, Paul V ^a   Holly, Jeff M P ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Apoptosis; Ceramide; Human breast epithelial cells; IGFBP 1 6

Indexed keywords

CERAMIDE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6;

APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL CULTURE; CELL GROWTH; CELL STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL SIZE; CELL SURVIVAL; CERAMIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; LIGANDS; OLIGOPEPTIDES; SOMATOMEDINS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0033573204     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19991215)75:4<652::AID-JCB11>3.0.CO;2-0     Document Type: Article

References (41)

1. Andress DL. 1998. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. Am J Physiol Endocrinol Metab 274: E744-E750.
2. Andress DL, Birnbaum RS. 1992. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267:22467-22472.
3. Baxter RC. 1993. IGF binding protein-3 and the acid-labile subunit: formation of the ternary complex in vitro and in vivo. Adv Exp Med Biol 343:237-244.
4. Blum WF, Jenne EW, Reppin F, Kietzmann K, Ranke MB, Bierich JR. 1989. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology 125:766-772.
5. Clemmons DR. 1992. IGF binding proteins: regulation of cellular actions. Growth Regul 2:80-87.
6. Clemmons DR, Camacho-Hubner C, Coronado E, Osborne CK. 1990. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology 127:2679-2686.
7. El Roiey A, Chen X, Roberts VJ, Shimasaki S, Ling N, LeRoith D, Roberts CT Jr, Yen SSC. 1994. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins 1-6 and the localization of the gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 78:1488-1496.
8. Fowler CA, Perks CM, Holly JMP, Farndon JR. 1998. The role of IGFBP-3 in modulating paclitaxel-induced apoptosis in human breast cancer cells. Br J Surg 85:1569.
9. Fowlkes JL, Thrailkill KM, George-Nascimento C, Rosenberg CK, Serra DM. 1997. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation. Endocrinology 138: 2280-2285.
10. Freedman VH, Shin S. 1974. Cellular tumorigenicity in nude mice: correlation with cell growth in semisolid medium. Cell 3:353-359.
11. Frisch SM, Francis H. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626.
12. 1, fibronectin receptor suppress the transformed phenotype of CHO cells. Cell 60:849-859.
13. Gill ZP, Perks C M, Newcomb PV, Holly JMP. 1998. IGFBP-3 can differentially accentuate apoptotic pathways in Hs578T human breast cancer cells in a non-IGF-dependent manner. J Endocrinol 156:OC25.
14. Gill ZP, Perks CM, Newcomb PV, Holly JMP. 1997. Insulin-like growth factor binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF dependent manner. J Biol Chem 272:25602-25607.
15. Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG. 1996. Insulin-like growth factor binding protein 3 mediates retinoic acid-and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Res 56:1545-1550.
16. Hayman EG, Pierschbacher MD, Ruoslahti E. 1985. Detachment of cells from culture substrate by soluble fibronectin peptides. J Cell Biol 100:1948-1954.
17. Hollowood AD, Lai T, Perks CM, Newcomb PV, Holly JMP, Alderson D. 1998. Insulin-like growth factor binding protein-3 (IGFBP-3) predisposes oesophageal cancer cells to apoptosis in a p53-dependent manner. In: BACR RSM meeting on carcinogenesis and chemoprevention, London. Abstract 1.5.
18. Huynh H, Yang XF, Pollack M. 1996. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 271:1016-1021.
19. Jaques G, Noll K, Wegmann B, Witten S, Kogan E, Radulescu RT, Havemann K. 1997. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology 138:1767-1770.
20. Ingber DE. 1990. Fibronectin controls capillary endothelial cell growth based on its ability to modulate cell shape. Proc Natl Acad Sci USA 87:3579-3583.
21. Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocrinol Rev 16:3-34.
22. 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 90:10553-10557.
23. Knudson KA, Rao PE, Damsky CH, Buck CA. 1981. Membrane glycoproteins involved in cell-substratum interactions. Proc Natl Acad Sci USA 78:6071-6075.
24. Lalou C, Lassarre C, Binoux M. 1996. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind the IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137:3206-3212.
25. Noll K, Wegmann B, Havemann K, Jaques G. 1996. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines. J Clin Endocrinol Metab 81:2653-2662.
26. Obeid LM, Linardic CM, Karolak LA, Hannun YA. 1993. Programmed cell death induced by ceramide. Science 259:1769-1771.
27. Oh Y, Möller, HL, Lamson G, Rosenfeld RG. 1993. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 268:14964-14971.
28. Oh Y, Möller HL, Ng L, Rosenfeld RG. 1995. Insulin-like growth factor binding protein 3 mediates retinoic acid-and transforming growth factor beta 2-induced growth inhibition in human breast cancer cells. J Biol Chem 270:13589-13592.
29. Oh Y, Nagalla SR, Yamanaka Y, Kim H-S, Wilson E, Rosenfeld RG. 1996. Synthesis and characterisation of insulin-like growth factor-binding protein (IGFBP)-7. J Biol Chem 271:30322-30325.
30. Perks CM, Newcomb PV, Norman MR, Holly JMP. 1999, Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells. J Mol Endocrinol 22:141-150.
31. Rajah R, Valentinis B, Cohen P. 1997. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-betal on programmed cell death through a p53-and IGF-independent mechanism. J Biol Chem 272:12181-12188.
32. Rechler MM. 1993. Insulin-like growth factor binding proteins. Vitam Horm 47:1-114.
33. Ritvos O, Ranta T, Jalkanen J, Suikkari AM, Voutilainen R, Bohn H, Rutanen EM. 1988. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 122:2150-2157.
34. Ruoslahti E, Pierschbacher MD. 1987. New perspectives in cell adhesion. Science 238:491-497.
35. Sheikh MS, Shao Z-M, Clemmons DR, LeRoith D, Roberts CT Jr, Fontana JA. 1992. Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells. Biochem Biophys Res Commun 183:1003-1010.
36. Shimasaki S, Shimonaka M, Zhang HP, Ling N. 1991. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 266:10646-10653.
37. Thompson CB. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
38. Tonner E, Barber MC, Travers MT, Logan A, Flint DJ. 1997. Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat. Endocrinology 138:5101-5107.
39. Tucker RW, Butterfield CE, Folkman J. 1981. Interaction of serum and cell spreading affects growth of neoplastic and nonneoplastic cells. J Supramol Struct 15:29-40.
40. Valentinis B, Reiss K, Baserga R. 1998. Insulin-like growth factor-I-mediated survival from anoikis: a role of cell aggregation and focal adhesion kinase. J Cell Physiol 176:648-57.
41. Wyllie AH. 1980. Cell death: the significance of apoptosis. Int Rev Cytol 60:251-306.